BRPI1012055A2 - "piperidinas substituídas" - Google Patents
"piperidinas substituídas"Info
- Publication number
- BRPI1012055A2 BRPI1012055A2 BRPI1012055A BRPI1012055A BRPI1012055A2 BR PI1012055 A2 BRPI1012055 A2 BR PI1012055A2 BR PI1012055 A BRPI1012055 A BR PI1012055A BR PI1012055 A BRPI1012055 A BR PI1012055A BR PI1012055 A2 BRPI1012055 A2 BR PI1012055A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted piperidines
- piperidines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009022896A DE102009022896A1 (de) | 2009-05-27 | 2009-05-27 | Substituierte Piperidine |
PCT/EP2010/003059 WO2010136144A1 (de) | 2009-05-27 | 2010-05-19 | Substituierte piperidine |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1012055A2 true BRPI1012055A2 (pt) | 2016-05-17 |
Family
ID=42543057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1012055A BRPI1012055A2 (pt) | 2009-05-27 | 2010-05-19 | "piperidinas substituídas" |
Country Status (28)
Country | Link |
---|---|
US (2) | US20120220563A1 (pt) |
EP (1) | EP2435427A1 (pt) |
JP (1) | JP5718320B2 (pt) |
KR (1) | KR20120044289A (pt) |
CN (2) | CN102596944B (pt) |
AR (1) | AR076692A1 (pt) |
AU (1) | AU2010252345A1 (pt) |
BR (1) | BRPI1012055A2 (pt) |
CA (1) | CA2763400A1 (pt) |
CL (1) | CL2011002965A1 (pt) |
CO (1) | CO6470823A2 (pt) |
CR (1) | CR20110628A (pt) |
CU (1) | CU20110215A7 (pt) |
DE (1) | DE102009022896A1 (pt) |
DO (1) | DOP2011000364A (pt) |
EA (1) | EA201190312A1 (pt) |
EC (2) | ECSP11011483A (pt) |
GT (1) | GT201100300A (pt) |
IL (1) | IL215901A0 (pt) |
MA (1) | MA33290B1 (pt) |
MX (1) | MX2011012505A (pt) |
PE (1) | PE20120934A1 (pt) |
SG (1) | SG175753A1 (pt) |
TN (1) | TN2011000595A1 (pt) |
TW (1) | TW201109326A (pt) |
UY (2) | UY32636A (pt) |
WO (1) | WO2010136144A1 (pt) |
ZA (1) | ZA201108565B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009014484A1 (de) | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022892A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022894A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
UY34365A (es) | 2011-10-07 | 2013-05-31 | Takeda Pharmaceutical | Compuestos heterociclicos |
CN109311874B (zh) | 2016-04-20 | 2021-07-30 | 百时美施贵宝公司 | 经取代的二环杂环化合物 |
EA201991095A1 (ru) | 2016-11-03 | 2019-09-30 | Бристол-Маерс Сквибб Компани | Замещенные азотсодержащие соединения |
WO2018222795A1 (en) | 2017-06-01 | 2018-12-06 | Bristol-Myers Squibb Company | Substituted nitrogen containing compounds |
WO2023044364A1 (en) | 2021-09-15 | 2023-03-23 | Enko Chem, Inc. | Protoporphyrinogen oxidase inhibitors |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767144A (en) | 1994-08-19 | 1998-06-16 | Abbott Laboratories | Endothelin antagonists |
WO1997036873A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
US6403612B2 (en) | 2000-01-31 | 2002-06-11 | Merck & Co., Inc. | Thrombin receptor antagonists |
JP4418676B2 (ja) | 2001-10-15 | 2010-02-17 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 虚血性損傷を減らすための置換された4−フェニル−4−(1h−イミダゾール−2−イル)−ピペリジン誘導体 |
AU2003224632A1 (en) * | 2002-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Hppars activators |
JP2008504279A (ja) | 2004-06-24 | 2008-02-14 | インサイト・コーポレイション | アミド化合物およびその医薬としての使用 |
AU2005258248A1 (en) | 2004-06-24 | 2006-01-05 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
UA95769C2 (ru) * | 2004-06-24 | 2011-09-12 | Инсайт Корпорейшн | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов |
MXPA06014574A (es) | 2004-06-24 | 2007-03-12 | Incyte Corp | Piperidinas n-sustituidas y su uso como farmaceuticos. |
US20060122197A1 (en) | 2004-08-10 | 2006-06-08 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
JP2007008913A (ja) * | 2004-09-17 | 2007-01-18 | Tanabe Seiyaku Co Ltd | ピペリジン化合物およびその製法 |
DE102004045796A1 (de) | 2004-09-22 | 2006-03-23 | Merck Patent Gmbh | Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung |
DE102004061750A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Heteroaryl-substituierte Pyrazoline |
US20070066584A1 (en) | 2005-09-21 | 2007-03-22 | Wenqing Yao | Amido compounds and their use as pharmaceuticals |
EA200870216A1 (ru) | 2006-01-31 | 2009-02-27 | Инсайт Корпорейшн | Амидо соединения и их применение в качестве лекарственных средств |
WO2007101270A1 (en) | 2006-03-02 | 2007-09-07 | Incyte Corporation | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME |
CA2649677A1 (en) | 2006-05-01 | 2007-11-15 | Incyte Corporation | Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1 |
DE502008003324D1 (de) | 2007-11-30 | 2011-06-01 | Bayer Schering Pharma Ag | Heteroaryl-substituierte piperidine |
DE102009014484A1 (de) * | 2009-03-23 | 2010-09-30 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022896A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022894A1 (de) | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
DE102009022897A1 (de) * | 2009-05-27 | 2010-12-02 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Piperidine |
-
2009
- 2009-05-27 DE DE102009022896A patent/DE102009022896A1/de not_active Withdrawn
-
2010
- 2010-05-13 UY UY0001032636A patent/UY32636A/es not_active Application Discontinuation
- 2010-05-13 UY UY0001032638A patent/UY32638A/es not_active Application Discontinuation
- 2010-05-19 EA EA201190312A patent/EA201190312A1/ru unknown
- 2010-05-19 PE PE2011002010A patent/PE20120934A1/es not_active Application Discontinuation
- 2010-05-19 EP EP10724697A patent/EP2435427A1/de not_active Withdrawn
- 2010-05-19 SG SG2011076833A patent/SG175753A1/en unknown
- 2010-05-19 JP JP2012512238A patent/JP5718320B2/ja not_active Expired - Fee Related
- 2010-05-19 US US13/321,966 patent/US20120220563A1/en not_active Abandoned
- 2010-05-19 CN CN201080036227.1A patent/CN102596944B/zh not_active Expired - Fee Related
- 2010-05-19 KR KR1020117028157A patent/KR20120044289A/ko not_active Application Discontinuation
- 2010-05-19 WO PCT/EP2010/003059 patent/WO2010136144A1/de active Application Filing
- 2010-05-19 CA CA2763400A patent/CA2763400A1/en not_active Abandoned
- 2010-05-19 MX MX2011012505A patent/MX2011012505A/es active IP Right Grant
- 2010-05-19 CN CN201510061018.7A patent/CN104744452A/zh active Pending
- 2010-05-19 AU AU2010252345A patent/AU2010252345A1/en not_active Abandoned
- 2010-05-19 BR BRPI1012055A patent/BRPI1012055A2/pt not_active IP Right Cessation
- 2010-05-19 MA MA34375A patent/MA33290B1/fr unknown
- 2010-05-20 AR ARP100101749A patent/AR076692A1/es not_active Application Discontinuation
- 2010-05-26 TW TW099116745A patent/TW201109326A/zh unknown
- 2010-05-27 US US12/788,529 patent/US8084469B2/en not_active Expired - Fee Related
-
2011
- 2011-10-25 IL IL215901A patent/IL215901A0/en unknown
- 2011-11-22 ZA ZA2011/08565A patent/ZA201108565B/en unknown
- 2011-11-24 CO CO11161612A patent/CO6470823A2/es not_active Application Discontinuation
- 2011-11-24 TN TNP2011000595A patent/TN2011000595A1/en unknown
- 2011-11-24 CL CL2011002965A patent/CL2011002965A1/es unknown
- 2011-11-24 CR CR20110628A patent/CR20110628A/es unknown
- 2011-11-24 DO DO2011000364A patent/DOP2011000364A/es unknown
- 2011-11-25 CU CU20110215A patent/CU20110215A7/es unknown
- 2011-11-25 GT GT201100300A patent/GT201100300A/es unknown
- 2011-11-25 EC EC2011011483A patent/ECSP11011483A/es unknown
- 2011-11-25 EC EC2011011482A patent/ECSP11011482A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SMT201500053B (it) | 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori | |
BR112012012872A2 (pt) | "pirrolindinas de espiroindolinona" | |
DK2610258T3 (da) | Substituerede piperidindihydrothienopyrimidiner | |
DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
BRPI0910229A2 (pt) | Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos | |
BRPI1015540A2 (pt) | ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750'' | |
BRPI1010909A2 (pt) | "inseticida arilpirrolinas" | |
FR2941508B1 (fr) | Agencement d'entrainement | |
BR112012004593A2 (pt) | "método" | |
BRPI1008774A2 (pt) | espiroamida substituída | |
BRPI1013015A2 (pt) | "osteosíntese com nanoprata" | |
UY33125A (es) | Diaza-espiro-[5,5]-undecanos | |
FR2950411B1 (fr) | Agencement d'entrainement | |
BRPI0914533A2 (pt) | "métodos" | |
BRPI1012055A2 (pt) | "piperidinas substituídas" | |
BR112012002336A2 (pt) | compostos aza-heterocíclicos | |
BRPI0915562A2 (pt) | tamis melhorado | |
BRPI0915442A2 (pt) | tamis melhorado | |
BR112012003701A2 (pt) | "novos antagonistas de quinolina-hepcidina" | |
BRPI1010778A2 (pt) | "escada dupla" | |
BRPI1012775A2 (pt) | piperidinas substituídas | |
BRPI1006474A2 (pt) | "gatilho" | |
BRPI1009730A2 (pt) | "recipiente" | |
MA30860B1 (fr) | Myrtillier denomme "c97-390" | |
DK2181990T3 (da) | Piperidinderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |